CP
Insider
Christopher Patusky
DirectorChristopher Patusky (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $1.7M of UTHR (2,910 sh × $569.00, as filed), executed Apr 24.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.7M
shares × price, as filed
Last traded
Apr 24
Filed Apr 24
Median ADV $265.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
UTHRRecent filings
UTHRSALE
United Therapeutics Corporation
View filing →
$1.7M2,910 sh × $569.00
Exec Apr 24
Filed Apr 24 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $579K
1,000 sh × $578.88
Exec Apr 17
Filed Apr 17 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $496K
1,000 sh × $495.95
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $1.4M
4,600 sh across 5 lots
Exec Mar 19 2025
Filed Mar 20 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $1.8M
4,891 sh across 5 lots
Exec Jan 10 2025
Filed Jan 13 2025 · 5:30 PM ET